Richard Scartozzi MD , FACS, FICS, FAAO, FAPCR, CPI

Retinal Disease

Dr. Richard Scartozzi, MD, FACS, FICS, FAAO, FAPCR, CPI, specializes in diseases and surgery of the retina, macula, and vitreous as a Vitreoretinal Surgeon, Partner, Principal Investigator & Medical Director of Clinical Research at Connecticut Eye Consultants

Join to view full profile

69 Sand Pit RdDanbury, CT 06810
Phone+1 203-791-2020
Fax+1 203-778-6238

Dr. Scartozzi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Scartozzi's full profile Already have an account?

Summary

Dr. Richard Scartozzi is an ophthalmologist based in Danbury, CT, specializing in retinal diseases. He completed his medical education at Johns Hopkins University School of Medicine, followed by a residency at Wills Eye Hospital and a fellowship in Surgical Retina and Vitreous at USC. Dr. Scartozzi has been a vitreoretinal surgeon, partner, and principal investigator at Connecticut Eye Consultants since 2011. His experience includes conditions like diabetic retinopathy and uveitis. He has published extensively in reputable journals and participated in multiple clinical trials concerning age-related macular degeneration and diabetic retinopathy. Recognized for his contributions to clinical research, he holds certifications and fellowships from notable professional organizations.

Education & Training

University of Southern California/LAC+USC Medical CenterFellowship, Surgical Retina and Vitreous, 2006 - 2008
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 2003 - 2006
Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 2002 - 2003
Johns Hopkins University School of MedicineClass of 2002, M.D., Class Rank: 14 of 114
SUNY at Stony BrookB.S., Biochemistry, Valedictorian, 1994 - 1998

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2006 - Present
NY State Medical License 2008 - 2028
CT State Medical License 2007 - 2027
PA State Medical License 2003 - 2006
American Board of Ophthalmology Ophthalmology
Association of Clinical Research ProfessionalsCertified Principal Investigator

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2015-2017
CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2015-2017
Fellow (FAPCR) Academy of Physicians in Clinical Research, 2016

Clinical Trials

Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
COMPLETED
PHASE3
Efficacy and Safety of RTH258 Versus Aflibercept - Study 1 Start of enrollment: 2014 Dec 08
COMPLETED
PHASE3
Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy Start of enrollment: 2015 Sep 24
COMPLETED
PHASE2

Publications & Presentations

PubMed

72 citations
Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy
Abdhish R. Bhavsar, Karisse Torres, Roy W. Beck, Neil M. Bressler, Frederick L. Ferris
JAMA Ophthalmology. 2013-03-01
11 citations
Non-cytomegalovirus Ocular Opportunistic Infections in Patients With Acquired Immunodeficiency Syndrome
Sapna Gangaputra, Lea T. Drye, Vijay Vaidya, Jennifer E. Thorne, Douglas A. Jabs
American Journal of Ophthalmology. 2013-02-01
95 citations
Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy
Elizabeth A. Sugar, Douglas A. Jabs, Alka Ahuja, Jennifer E. Thorne, Ronald P. Danis
American Journal of Ophthalmology. 2012-06-01